Chapter 4. The Pharmacology of Typical and Atypical Antipsychotics

  1. Stewart A. Factor DO1,
  2. Anthony E. Lang MD2 and
  3. William J. Weiner MD3
  1. Gary Remington and
  2. Shitij Kapur

Published Online: 14 JAN 2008

DOI: 10.1002/9780470753217.ch4

Drug Induced Movement Disorders, Second Edition

Drug Induced Movement Disorders, Second Edition

How to Cite

Remington, G. and Kapur, S. (2005) The Pharmacology of Typical and Atypical Antipsychotics, in Drug Induced Movement Disorders, Second Edition (eds S. A. Factor, A. E. Lang and W. J. Weiner), Blackwell Publishing Inc., Malden, Massachusetts, USA. doi: 10.1002/9780470753217.ch4

Editor Information

  1. 1

    Movement Disorders Center, Department of Neurology, Emory University, Atlanta, USA

  2. 2

    Movement Disorders Clinic, Toronto Western Hospital, Toronto, Canada

  3. 3

    Department of Neurology, University of Maryland School of Medicine, Baltimore, USA

Publication History

  1. Published Online: 14 JAN 2008
  2. Published Print: 1 JAN 2005

ISBN Information

Print ISBN: 9781405126199

Online ISBN: 9780470753217

SEARCH

Keywords:

  • atypical antipsychotics;
  • schizophrenia;
  • dopamine agonism;
  • sedation;
  • chlorpromazine

Summary

This chapter contains section titled:

  • The introduction of antipsychotics

  • Dopamine, schizophrenia, and the D2 receptor

  • Clozapine and the concept of “atypicality”

  • The pharmacology of “atypical”